BJDX bluejaydx.com: Earnings growth forecast for next year
The growth of Bluejay Diagnostics (BJDX) relies on FDA approval of rapid sepsis tests and the sale of consumables. The projected EPS trend for the company for the coming year visualizes market expectations, where the value of 0.00 represents the most recent figure. Robotic systems automate bedside blood analysis, while management cohesion ensures the precise execution of the technology commercialization plan.
Metric breakdowns and analytics for bluejaydx.com (BJDX)
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization indicators:
- debt and solvency information:
Total Debt to Capital Bluejay Diagnostics|BJDX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Bluejay Diagnostics, Inc.|BJDX - Company Cumulative Indebtedness|Debts to Book Capitalization Bluejay Diagnostics|BJDX - Company Long-Term Debts|Company Current Liabilities Bluejay Diagnostics|Quick Liquidity Indicator bluejaydx.com
- net income and valuation ratios data:
BJDX - Final Profit|Projected Future Earnings Bluejay Diagnostics|BJDX - Price to Earnings Multiple|Forward P/E Multiple Bluejay Diagnostics|BJDX - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Bluejay Diagnostics|BJDX - Operating profit EBITDA|Net earnings per share (EPS TTM) Bluejay Diagnostics|BJDX - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months bluejaydx.com|BJDX - Earnings per share growth this year|Net earnings per share growth forecast for next year Bluejay Diagnostics
Fundamental valuation:Bluejay, BJDX
This indicator reflects the analysts' consensus forecast for the change in net earnings per share for the coming year, measuring the expected business profitability trend. By analyzing the one-year forward EPS growth rate, an investor assesses the scaling potential of Bluejay Diagnostics (BJDX), where the implementation of robotic point-of-care rapid tests should radically reduce operating expenses and accelerate expansion within the diagnostics market.
Main competitors
Net earnings per share growth forecast for next year Agilent Tech|Quest Corp (DGX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ILMN|Net earnings per share growth forecast for next year EXAS (exactsciences.com)|Net earnings per share growth forecast for next year Revvity RVTY|Bio-Rad Laboratories, Inc. - Net earnings per share growth forecast for next year|NNNN: Expected earnings per share growth for next year|SHC - Earnings growth forecast for next year|QDEL: Earnings growth forecast for next year|Expected net earnings per share growth next year opko.com (OPK)|Net earnings per share growth forecast for next year CareDx, Inc.|MRVI (Maravai LifeSciences Holdings) - Projected earnings per share increase next year|Earnings growth forecast for next year FLGT|Earnings growth forecast for next year Standard BioTools Corp (LAB)|Cytek Biosciences, Inc. - Expected earnings per share growth for next year|orasure.com (OSUR) - Expected net earnings per share growth next year|XGN: Expected earnings per share growth for next year|Expected earnings per share trend next year MDXH (MDxHealth S.A.)|LUCD: Earnings growth forecast for next year|Projected earnings per share growth rate for next year PRE|IMDX (Insight Molecular Diagnostics, Inc.) - Earnings growth forecast for next year|Trinity Biotech Corp (TRIB) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year PRPH|Earnings growth forecast for next year Ainos Inc (AIMD)|Earnings growth forecast for next year CODX (Co-Diagnostics Corp)|Net earnings per one share growth forecast for next year Heart Test Labs|BMRA - Net earnings per share growth forecast for next year|CDIO (Cardio Diagnostics) - Projected earnings per share growth rate for next year|Onconetix (ONCO) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Virax Biolabs Group Limited (VRAX)|Net earnings per share growth forecast for next year Vermillion|Accelerate Diagnostics Inc (AXDX) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year CNTG (Centogene NV)|Projected earnings per share increase next year ENZ|Earnings growth forecast for next year FRES (Fresh2 Group)|Consensus forecast of earnings per share growth for next year Genetic Technologies Ltd (GENE)|23andMe Inc. - Earnings growth forecast for next year|Psychemedics Inc (PMD) - Expected earnings per share growth for next year
